A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know

Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month starting in July, a notable shift for Medicare which has long been barred from covering weight loss treatments. The drugs, such as Wegovy and Zepbound, are effective but can be expensive without insurance coverage. This new benefit is part of the Medicare GLP-1 Bridge program, a short-term pilot program.